MedTrace Logo

ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants

NCT07334080 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-01-16

No results posted yet for this study

Summary

This is a Phase I, open-label, randomized, single-dose, 2-part study designed to evaluate the food effect and relative bioavailability of ECC4703 in healthy adult participants.

Conditions

Interventions

DRUG

ECC4703 F0 formulation

A single dose of ECC4703 F0

DRUG

ECC4703 F1 formulation

A single dose of ECC4703 F1

DRUG

ECC4703 F2 formulation

A single dose of ECC4703 F2

DRUG

ECC4703 F3 formulation

A single dose of ECC4703 F3

Sponsors & Collaborators

  • Eccogene

    lead INDUSTRY

Principal Investigators

  • Eccogene Clinical Trials · Eccogene

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-10
Primary Completion
2026-05-31
Completion
2026-05-31
FDA Drug
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07334080 on ClinicalTrials.gov